BRISTOL WOULD PROVIDE ZERIT ONE MONTH FREE
Executive Summary
BRISTOL WOULD PROVIDE ZERIT ONE MONTH FREE in a Treatment IND wind-down if the drug is approved by FDA following analysis of the findings of the Antiviral Drugs Advisory Committee that met May 20. The panel voted that there is a population needing the drug and that stavudine/d4T is effective but bogged down in discussions on Zerit's safety ("The Pink Sheet" May 23, T&G-1).